로딩 중…
지수 로딩 중…
LifeMD, Inc.
LFMDP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$23.46-0.09%
2026-08-03
Financials
Valuation Metrics
LifeMD, Inc.'s Market Cap is $160M. At end of 2025 it was $1.03B. Ranked #3051 of 3,112 in US market (top 98%), #1394 of 1,445 on NASDAQ (top 96%), #259 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 96%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $160M | US#3,051/3,112 Sec#259/269 |
| Revenue | $219M | US#2,655/3,112 Sec#109/269 |
| Net Income | $-16M | US—/3,112 Sec—/269 |
| Total Assets | $70M | US#3,047/3,112 Sec#268/269 |
| Net Assets | $15M | US#2,985/3,112 Sec#256/269 |
| Value | ||
| P/B | 10.64x | US#2,638/3,112 Sec#208/269 |
| P/S | 0.73x | US#447/3,112 Sec#10/269 |
| FCF Yield | 9.27% | US#570/3,112 Sec#19/269 |
| Profitability | ||
| ROE | -108.07% | US#2,858/3,112 Sec#223/269 |
| ROA | -23.17% | US#2,811/3,112 Sec#136/269 |
| Op. Margin | -5.88% | US#2,579/3,112 Sec#92/269 |
| Revenue Growth | -23.65% | US#2,799/3,112 Sec#154/269 |
| Earnings Growth | -740.71% | US#2,353/3,112 Sec#92/269 |
| Financial Health | ||
| Debt Ratio | 366.35% | US#2,244/3,112 Sec#223/269 |
| Total Debt | $6M | US#2,831/3,112 Sec#211/269 |
| FCF | $15M | US#2,179/3,112 Sec#78/269 |
| Cash | $34M | US#2,727/3,112 Sec#247/269 |
| Current Ratio | 1.04x | US#2,220/3,112 Sec#259/269 |
| Dividend | ||
| Div. Yield | 0.49% | US#1,526/3,112 Sec#23/269 |
| Performance | ||
| 1Y Return | -2.25% | US#2,173/3,112 Sec#200/269 |
| 1M Return | 0.39% | US#1,589/3,112 Sec#71/269 |
| From 52W High | -3.26% | US#365/3,112 Sec#12/269 |
| 1Y MDD | -20.16% | US#690/3,112 Sec#26/269 |
| Trading | ||
| Volume | 2,136 shares | US#3,119/3,112 Sec#269/269 |
| Trading Value | $50110.00 | US#3,118/3,112 Sec#269/269 |
| Per Share | ||
| EPS | $-0.13 | US—/3,112 Sec—/269 |
| BPS | $0.50 | US#2,680/3,112 Sec#220/269 |